April 29, 2020Open Access

Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors

Key Points

Key points are not available for this paper at this time.

Abstract

In patients with advanced NSCLC treated with PD-1 inhibitors, pretreatment NLR, LDH, and PNI may be useful predictive markers of clinical outcome and irAEs.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Lihong Peng

Yong Wang

Fen Liu

Journals

Cancer Immunology Immunotherapy

Actions

Institutions

Nanchang University

First Affiliated Hospital of Nanchang University

Ganzhou People's Hospital

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study